Hosein Rafiemanesh
- Oncology top 5%
- Global Cancer Incidence and Screening 13
- Colorectal Cancer Screening and Detection 13
- Cancer survivorship and care 4
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 15
- Family Practice top 10%
- General Dentistry top 10%
-
- Cystic Fibrosis Research Advances 4
-
- HIV, Drug Use, Sexual Risk 4
- Substance Abuse Treatment and Outcomes 4
-
- Blood disorders and treatments 4
- Co-authors
- Abbas BalouchiMehrbanoo AmirshahiHamid SalehiniyaSeyed-Mehdi HashemiSalehoddin BouyaNiaz BehnamfarRoghaiyeh AfsargharehbaghMahin Badakhsh
- Cited by
- OncologyImmunologyFamily Practice
- Journals
- SHILAP Revista de lepidopterología (6 papers)PLoS ONE (1 paper)Addiction (1 paper)
- Partner nations
- IranSwedenUnited States
In The Last Decade
Hosein Rafiemanesh
83 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 154
- Oncology 737
- Immunology 333
- Family Practice 32
- General Dentistry 25
- Radiological and Ultrasound Technology 66
Countries citing papers authored by Hosein Rafiemanesh
This map shows the geographic impact of Hosein Rafiemanesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hosein Rafiemanesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hosein Rafiemanesh more than expected).
Fields of papers citing papers by Hosein Rafiemanesh
This network shows the impact of papers produced by Hosein Rafiemanesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hosein Rafiemanesh. The network helps show where Hosein Rafiemanesh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hosein Rafiemanesh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 64 | |
| 11 | 2019 | 7 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 16 | |
| 14 | 2018 | 16 | |
| 15 | An Overview of the Tools and Screening Tests for Detection of Alcohol Disorders | 2017 | 4 |
| 16 | Trend of some Tuberculosis Indices in Iran during 25 yr Period (1990-2014). | 2016 | 8 |
| 17 | 2016 | 46 | |
| 18 | Epidemiology and Trends of Mortality from prostate cancer in Iran | 2015 | 1 |
| 19 | 2015 | 46 | |
| 20 | 2015 | 86 |
About Hosein Rafiemanesh
Hosein Rafiemanesh is a scholar working on Oncology, Epidemiology and Immunology, having authored 88 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (15 papers), Global Cancer Incidence and Screening (13 papers), Colorectal Cancer Screening and Detection (13 papers), Cystic Fibrosis Research Advances (4 papers), Cancer survivorship and care (4 papers), HIV, Drug Use, Sexual Risk (4 papers), Blood disorders and treatments (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). The work is most often cited by research in Oncology (737 citations), Immunology (333 citations) and Family Practice (32 citations). Hosein Rafiemanesh has collaborated with scholars based in Iran, Sweden and United States. Frequent co-authors include Abbas Balouchi, Mehrbanoo Amirshahi, Hamid Salehiniya, Seyed-Mehdi Hashemi, Salehoddin Bouya, Niaz Behnamfar, Hamid Salehiniya, Roghaiyeh Afsargharehbagh, Mahin Badakhsh and Abdollah Mohammadian-Hafshejani. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Addiction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.